George Abu-Aita
Neurology · Hobart, INNPI 1710997929
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,622 and has fallen 95.0% since, to $80 in 2023.
Across 321 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$755
- Novartis$529
- Sunovion Pharmaceuticals Inc.$488
- Johnson & Johnson$332
- Sanofi$321
- Supernus Pharmaceuticals, Inc.$321
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$130%
- Food & beverage$4,66397%
- Education$1213%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $755 |
| Novartis | 34 | $529 |
| Sunovion Pharmaceuticals Inc. | 29 | $488 |
| Johnson & Johnson | 18 | $332 |
| Sanofi | 23 | $321 |
| Supernus Pharmaceuticals, Inc. | 31 | $321 |
| SK Life Science, Inc. | 18 | $249 |
| Lilly USA, LLC | 8 | $166 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $146 |
| Lundbeck LLC | 7 | $143 |
| Upsher-smith Laboratories LLC | 9 | $143 |
| Biohaven Pharmaceuticals, Inc. | 6 | $117 |
| Teva Pharmaceuticals USA, Inc. | 5 | $100 |
| Biogen | 6 | $88 |
| Genentech USA, Inc. | 6 | $86 |
| EMD Serono, Inc. | 6 | $82 |
| Eisai Inc. | 4 | $78 |
| Arbor Pharmaceuticals, Inc. | 5 | $67 |
| Almatica Pharma LLC | 4 | $64 |
| Sanofi-aventis U.S. LLC | 2 | $60 |
| AstraZeneca(2 entities) | 4 | $56 |
| Neurelis, Inc. | 3 | $49 |
| Amgen | 3 | $46 |
| Corium, LLC | 4 | $45 |
| Abbott | 2 | $44 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| UCB, Inc. | 2 | $32 |
| Livanova USA, Inc. | 2 | $31 |
| Adamas Pharmaceuticals, Inc. | 2 | $26 |
| Acorda Therapeutics, Inc | 2 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
| MDD US Operations, LLC | 1 | $11 |
| Assertio Therapeutics, Inc. | 1 | $11 |
How this compares
$4,796 in reported general payments places this provider in the 60th percentile of 308 neurology providers in Indiana.
Other neurology in Hobart
- William ConteMerrillville$1.2M
- Anthony SimchakLafayette$720K
- Mark JanickiLebanon$573K
- Ajay GuptaFort Wayne$411K
- Roderick WarrenEvansville$296K
- Ender AkanMunster$296K
- Christopher WilsonAvon$283K
- Marlene BultemeyerFort Wayne$277K
- Jerry SmarttCarmel$254K
- Andrea HallerFort Wayne$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.